ArticleBMC cancer2026
Outreach to Native Hawaiian and Pacific Islander communities to increase breast cancer screening and clinical trial awareness.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Racial and ethnic minority groups, including Native Hawaiian and Pacific Islander (NHPI) communities, experience multilevel barriers to cancer screening and enrollment into cancer clinical trials. Such barriers include low health literacy, mistrust in the healthcare system, and access to affordable healthcare. To address these barriers, a pilot outreach program was developed with the primary aims to build partnerships between rural Oahu communities and healthcare systems through collaboration between a Community Health Educator (CHE), a healthcare provider (HCP), and a clinic research coordinator (CRC); and identify and address barriers to breast cancer screening through a culturally appropriate, cost-effective approach, leveraging the CHE as the main intermediary to make real-time adjustments based on community needs.In this pilot program, we utilized a culturally congruent and gender concordant Community Health Educator (CHE), medical oncology health care provider (HCP), and clinic research coordinator (CRC) team to engage with Oahu's rural underserved communities to facilitate enrollment into the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) breast cancer screening trial.From June 2022 to June 2023, the CHE/HCP/CRC team facilitated 52 outreach events across Oahu that held approximately 20,000 attendees. A total of 92 women were screened for TMIST. Of those, 12 were enrolled in TMIST and an additional 32 participants received mammograms. The CHE/HCP/CRC team provided breast cancer education, connected participants to screening opportunities, and gathered feedback on perceived barriers. Insights from participants highlighted the critical role of the CHE in building trust, improving understanding of breast cancer screening, and fostering connections between the community and healthcare services.This pilot program emphasizes the value of culturally tailored, community-based approaches in addressing screening disparities and strengthening partnerships in underserved populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.